This product is a targeted antiparasitic agent effective against liver flukes, including Fasciola hepatica and Fasciola gigantica. Its mechanism of action involves disruption of parasite metabolism and cellular structure, leading to parasite death at both immature and adult stages.
Recommended for:
Clinical studies and global medical practice confirm the high efficacy of triclabendazole. The drug is recommended by the World Health Organization for the treatment of fascioliasis, reinforcing its credibility and therapeutic value.
Used for the treatment of trematode infections, particularly fascioliasis. Acts by inhibiting vital biological processes of the parasite, resulting in its elimination from the body.
Administered orally after meals. Dosage and treatment duration are determined by a healthcare professional based on diagnosis, patient weight, and infection severity.
Contraindications
Side Effects
